Boussard & Gavaudan Investment Management LLP Merck & Co., Inc. Transaction History

Boussard & Gavaudan Investment Management LLP

$407 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$72.28 - $90.54 $28.8 Million - $36.1 Million	-399,026 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$71.68 - $78.83 $2.02 Million - $2.22 Million	28,175 Added 7.6%	399,026 $30 Million
Q2 2021 Aug 06, 2021	BUY	$70.31 - $77.77 $8.77 Million - $9.71 Million	124,793 Added 50.72%	370,851 $28.9 Million
Q1 2021 May 11, 2021	BUY	$68.86 - $81.11 $16.9 Million - $20 Million	246,058 New	246,058 $19 Million

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$25.8 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$21.4 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$12.3 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.82 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$6.1 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boussard & Gavaudan Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Boussard & Gavaudan Investment Management LLP with notifications on news.

Account